
AYTU
Healthcare · Drug Manufacturers - Specialty & Generic · $19.3M market cap
$1.78-0.01 (-0.6%)Nov 13, 4:00 PM EST
Next report
After the close
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · -800.0% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 16, 2026 · upcoming | After the close | -0.10 | — | — |
| Sep 22, 2026 | After the close | -0.22 | -0.05 | +77.3% |
| May 13, 2026 | After the close | -0.42 | -0.41 | +2.4% |
| Feb 3, 2026 | After the close | -0.49 | -0.23 | +53.1% |
| Nov 13, 2025 | After the close | -0.19 | -0.09 | +52.6% |
| Sep 23, 2025 | Time not confirmed | 0.53 | -2.93 | -652.8% |
| May 14, 2025 | After the close | -0.17 | 0.21 | +223.5% |
| Feb 12, 2025 | After the close | -0.28 | 0.13 | +146.4% |
| Nov 13, 2024 | After the close | -0.34 | -0.15 | +55.9% |
| Sep 25, 2024 | After the close | -0.45 | -0.82 | -82.2% |
| May 15, 2024 | After the close | -0.64 | -0.52 | +18.8% |
| Feb 14, 2024 | After the close | -0.25 | -0.04 | +84.0% |
| Nov 14, 2023 | After the close | -0.04 |
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT A central nervous system stimulant…
| -1.48 |
| -3600.0% |
| Sep 27, 2023 | After the close | -0.95 | -0.59 | +37.9% |
| May 11, 2023 | After the close | -0.80 | -1.93 | -141.3% |
| Feb 21, 2023 | After the close | 0.20 | -1.32 | -760.0% |
| Nov 14, 2022 | After the close | -3.60 | -1.20 | +66.7% |
| Sep 27, 2022 | After the close | -7.40 | -9.80 | -32.4% |
| May 16, 2022 | After the close | -8.20 | -35.80 | -336.6% |
| Feb 14, 2022 | After the close | -11.60 | -8.80 | +24.1% |
| Nov 15, 2021 | After the close | -1.60 | -6.44 | -302.5% |
| Sep 27, 2021 | After the close | -9.80 | -15.00 | -53.1% |
| May 17, 2021 | After the close | -6.30 | -21.82 | -246.3% |
| Feb 11, 2021 | After the close | -8.80 | -9.00 | -2.3% |
| Nov 12, 2020 | After the close | -11.00 | -8.00 | +27.3% |
| Sep 24, 2020 | Time not confirmed | -0.35 | -0.20 | +42.9% |
| May 15, 2020 | Before the open | -10.00 | -30.00 | -200.0% |
| Feb 14, 2020 | After the close | -68.00 | -2.00 | +97.1% |
| Nov 14, 2019 | After the close | -55.00 | -64.00 | -16.4% |
| Sep 26, 2019 | After the close | -66.00 | -84.12 | -27.5% |
| May 14, 2019 | Before the open | -116.00 | -100.00 | +13.8% |
| Feb 7, 2019 | Before the open | -79.00 | -144.00 | -82.3% |
| Nov 7, 2018 | After the close | -290.00 | -392.00 | -35.2% |
| Sep 6, 2018 | After the close | -18.60 | 0.29 | +101.6% |
| May 14, 2018 | After the close | -4000.00 | -960.00 | +76.0% |
| Feb 8, 2018 | After the close | -7120.00 | -3560.00 | +50.0% |